Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: A feasibility trial

Clinical Breast Cancer

Volumn 10, Issue 3, 2010, Pages 224-229

  Peppone, Luke J ^a   Mustian, Karen M ^a   Janelsins, Michelle C ^a   Palesh, Oxana G ^a   Rosier, Randy N ^a   Piazza, Kenneth M ^b   Purnell, Jason Q ^a   Darling, Tom V ^a   Morrow, Gary R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Bone loss; Bone specific alkaline phosphatase; Cytokines; NTx; Osteoblasts; Osteoclasts; Remodeling index

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BONE METABOLISM; BREAST CANCER; CANCER SURGERY; CANCER SURVIVOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONAL THERAPY; HUMAN; INTERMETHOD COMPARISON; MASTECTOMY; OSSIFICATION; OSTEOLYSIS; PILOT STUDY; TAI CHI;

EID: 77953005627     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2010.n.030     Document Type: Article

References (47)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96.
2. Centers for Disease Control and Prevention (CDC). Cancer survivorship-United States, 1971-2001. MMWR Morb Mortal Wkly Rep 2004; 53:526-529
3. Lester JE, Dodwell D, Horsman JM, et al. Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom. Br J Cancer 2006; 94:30-35
4. Saad F, Adachi JD, Brown JP, et al. Cancer treatment-induced bone loss in breast and prostate cancer. J Clin Oncol 2008; 26:5465-5476
5. Greep NC, Giuliano AE, Hansen NM, et al. The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer. Am J Med 2003;114:653-659
6. Hirbe A, Morgan EA, Uluckan O, et al. Skeletal complications of breast cancer therapies. Clin Cancer Res 2006; 12:6309s-14s.
7. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, Forbes JF, Cuzick J, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC Trial. Lancet Oncol 2008; 9:45-53.
8. Howell A, Cuzick J, Baum M, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005; 365:60-62
9. Baum M, Buzdar A, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 2003; 98:1802-1810
10. Coleman RE, Banks LM, Girgis SI, et al. Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study. Lancet Oncol 2007; 8:119-127
11. Lonning PE. Bone safety of aromatase inhibitors versus tamoxifen. Int J Gynecol Cancer 2006; 16(suppl 2):518-520
12. Limburg CE. Screening, prevention, detection, and treatment of cancer therapy-induced bone loss in patients with breast cancer. Oncol Nurs Forum 2007; 34:55-63.
13. Jakesz R, Jonat W, Gnant M, et al. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG Trial 8 and ARNO 95 Trial. Lancet 2005;366:455-462
14. Crivellari D, Sun Z, Coates AS, et al. Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. J Clin Oncol 2008; 26:1972-1979
15. Chen Z, Maricic M, Bassford TL, et al. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med 2005; 165:552-558
16. Kanis JA, McCloskey EV, Powles T, et al. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 1999; 79:1179-1181
17. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359:1761-1767
18. Braithwaite RS, Col NF, Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 2003; 51:364-370
19. Steiner JF, Kramer AM, Eilertsen TB, et al. Development and validation of a clinical prediction rule for prolonged nursing home residence after hip fracture. J Am Geriatr Soc 1997; 45:1510-1514
20. Magaziner J, Hawkes W, Hebel JR, et al. Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci 2000; 55:M498-507.
21. Borer KT. Physical activity in the prevention and amelioration of osteoporosis in women: interaction of mechanical, hormonal and dietary factors. Sports Med 2005; 35:779-830.
22. Chilibeck PD, Sale DG, Webber CE. Exercise and bone mineral density. Sports Med 1995; 19:103-122
23. Lee MS, Pittler MH, Shin BC, et al. Tai chi for osteoporosis: a systematic review. Osteoporos Int 2008; 19:139-146
24. Wang C, Collet JP, Lau J. The effect of Tai Chi on health outcomes in patients with chronic conditions: a systematic review. Arch Intern Med 2004; 164:493-501.
25. Wayne PM, Kiel DP, Krebs DE, et al. The effects of Tai Chi on bone mineral density in postmenopausal women: a systematic review. Arch Phys Med Rehabil 2007; 88:673-680
26. Murphy L, Singh BB. Effects of 5-form, Yang style Tai Chi on older females who have or are at risk for developing osteoporosis. Physiother Theory Pract 2008; 24:311-320
27. Qin L, Au S, Choy W, et al. Regular Tai Chi Chuan exercise may retard bone loss in postmenopausal women: a case-control study. Arch Phys Med Rehabil 2002; 83:1355-1359
28. Qin L, Choy W, Leung K, et al. Beneficial effects of regular Tai Chi exercise on musculoskeletal system. J Bone Miner Metab 2005; 23:186-190
29. Chan K, Qin L, Lau M, et al. A randomized, prospective study of the effects of Tai Chi Chun exercise on bone mineral density in postmenopausal women. Arch Phys Med Rehabil 2004; 85:717-722
30. Shen CL, Williams JS, Chyu MC, et al. Comparison of the effects of Tai Chi and resistance training on bone metabolism in the elderly: a feasibility study. Am J Chin Med 2007; 35:369-381
31. Dy GK, Bekele L, Hanson LJ, et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 2004; 22:4810-4815
32. Richardson MA, Sanders T, Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18:2505-2514
33. Mustian KM, Katula JA, Gill DL, et al. Tai Chi Chuan, health-related quality of life and self-esteem: a randomized trial with breast cancer survivors. Support Care Cancer 2004; 12:871-876
34. Mustian KM, Katula JA, Zhao H. A pilot study to assess the influence of Tai Chi Chuan on functional capacity among breast cancer survivors. J Support Oncol 2006; 4:139-145
35. Bauer DC, Sklarin PM, Stone KL, et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the Study of Osteoporotic Fractures. J Bone Miner Res 1999; 14:1404-1410
36. Watts NB. Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999; 45:1359-1368
37. Ross PD, Kress BC, Parson RE, et al. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 2000; 11:76-82.
38. Eastell R, Robins SP, Colwell T, et al. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int 1993; 3:255-260
39. Bassey EJ, Ramsdale SJ. Increase in femoral bone density in young women following high-impact exercise. Osteoporos Int 1994; 4:72-75
40. Taaffe DR, Robinson TL, Snow CM, et al. High-impact exercise promotes bone gain in well-trained female athletes. J Bone Miner Res 1997; 12:255-260
41. Jehle PM, Schulten K, Schulz W, et al. Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients. Eur J Intern Med 2003; 14:32-38
42. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98:1154-1162
43. Petersen AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol 2006; 57(suppl 10):43-51.
44. Caverzasio J, Higgins L, Ammann P. Prevention of trabecular bone loss induced by estrogen deficiency by a selective p38alpha inhibitor. J Bone Miner Res 2008; 23:1389-1397
45. D'Amelio P, Grimaldi A, Di Bella S, et al. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 2008; 43:92-100.
46. Bessoles S, Fouret F, Dudal S, et al. IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines. J Leukoc Biol 2008; 84:224-233
47. Gao Y, Grassi F, Ryan MR, et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 2007; 117:122-132